This inventor holds 1 USPTO granted patent. Top assignee: Df 2024 IP Acquisition, LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: David Lonergan: Innovator in Autotaxin Inhibition
Introduction
David Lonergan is an accomplished inventor based in San Marcos, CA (US). He has made significant contributions to the field of medical research, particularly in the development of treatments for conditions associated with autotaxin activity. His innovative work has led to the creation of a patent that addresses important health issues.
Latest Patents
David Lonergan holds a patent for "Autotaxin inhibitors and uses thereof." This patent describes methods and compositions for the treatment of conditions, diseases, or disorders linked to autotaxin activity. The disclosed methods and compositions include the use of at least one autotaxin inhibitor compound, showcasing his commitment to advancing medical science.
Career Highlights
David is currently associated with Df 2024 IP Acquisition, LLC, where he continues to explore innovative solutions in the field of biotechnology. His work is characterized by a focus on developing effective treatments that can improve patient outcomes.
Collaborations
David collaborates with talented individuals such as Gretchen Bain and Jillian Frances Evans. These partnerships enhance the research and development process, allowing for a more comprehensive approach to innovation.
Conclusion
David Lonergan's contributions to the field of autotaxin inhibition exemplify the impact of dedicated inventors in advancing medical treatments. His work not only highlights his innovative spirit but also underscores the importance of collaboration in achieving significant breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile